Gavel on flag The bipartisanproposal has gone through the Senate Finance Committee but therehasn't been a vote on it, with no sign that there ever will be.(Photo: Shutterstock)

The Prescription Drug Pricing Act, a joint effort betweenSenator Chuck Grassley, R-IA, and Senator Ron Wyden, D-OR, has beensitting in limbo on the Senate's legislative calendar "for months,"according to a Health Care Finance News.

But if it ever made it to an actual vote, the CongressionalBudget Office has estimated that it could save more than $94billion over the course of the next 10 years.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

Core and Group Health
Health Care Reform
Cost-Containment